Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkers

Higher levels of AD biomarkers, including among individuals with preclinical AD, lead to earlier driving cessation. Negative functional outcomes of preclinical AD show a nonbenign phase of the disease.